[Elsevier] [Supplementary]Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial |
|
This post will be closed automatically in 2026-08-03 04:19
Reward20points
|
post
reply
points
20
20
Six-Minute Walk Testing
10
Impact of microplastics exposure on liver health: A comprehensive meta-analysis
10
Environmental Microcystin exposure in underlying NAFLD-induced exacerbation of neuroinflammation, blood-brain barrier dysfunction, and neurodegeneration are NLRP3 and S100B dependent
10
Les bact谷ries multir谷sistantes et bact谷ries hautement r谷sistantes 谷mergentes
10
Inflation prediction in emerging economies: Machine learning and FX reserves integration for enhanced forecasting
